{'fraction_non_alphanumeric': 0.02553191489361702, 'fraction_numerical': 0.00425531914893617, 'mean_word_length': 6.128787878787879, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Cognitive function and neuroimaging correlates in a subjective cognitive decline population within a multimodal intervention supplemented with green tea extract (PENSA Study): Preliminary results of a voxel‐based morphometry study

Multicomponent interventions including diet, physical activity and cognitive training have shown great potential to prevent cognitive decline in individuals at risk of developing the clinical stages of Alzheimer’s disease (AD). The PENSA study is a clinical trial focused on the prevention of cognitive decline in individuals with subjective cognitive decline (SCD) who are also APOE ε4 carriers. It is based on a 12‐month multimodal intervention (nutritional, physical and cognitive) combined with epigallocatechin‐3‐gallate (EGCG), a natural flavanol and known synaptic plasticity booster. In this study, we sought for neuroimaging correlates of cognitive performance of the PENSA participants at baseline.